Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin.
about
TOX defines a conserved subfamily of HMG-box proteinsHMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoterSRY, like HMG1, recognizes sharp angles in DNAHigh mobility group protein-1 (HMG-1) is a unique activator of p53The SRY high-mobility-group box recognizes DNA by partial intercalation in the minor groove: a topological mechanism of sequence specificityThe RAG1 homeodomain recruits HMG1 and HMG2 to facilitate recombination signal sequence binding and to enhance the intrinsic DNA-bending activity of RAG1-RAG2Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatinHMG1 interacts with HOX proteins and enhances their DNA binding and transcriptional activationCorrection of the DNA repair defect in xeroderma pigmentosum group E by injection of a DNA damage-binding proteinInfluence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplexDNA and the chromosome - varied targets for chemotherapyHigh affinity binding of proteins HMG1 and HMG2 to semicatenated DNA loopsSolution structure of the HMG protein NHP6A and its interaction with DNA reveals the structural determinants for non-sequence-specific bindingSolution structure and backbone dynamics of the DNA-binding domain of mouse Sox-5HMG-D complexed to a bulge DNA: An NMR modelStructure of the HMG box motif in the B-domain of HMG1The Saccharomyces cerevisiae high mobility group box protein HMO1 contains two functional DNA binding domains.Determinants of DNA binding and bending by the Saccharomyces cerevisiae high mobility group protein NHP6A that are important for its biological activities. Role of the unique N terminus and putative intercalating methionine.DNA looping by Saccharomyces cerevisiae high mobility group proteins NHP6A/B. Consequences for nucleoprotein complex assembly and chromatin condensation.Structural maintenance of chromosomes protein C-terminal domains bind preferentially to DNA with secondary structure.Characterization of a high mobility group 1/2 homolog in yeast.The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsReview of Cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatmentsInteraction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 proteinInteraction of FACT, SSRP1, and the high mobility group (HMG) domain of SSRP1 with DNA damaged by the anticancer drug cisplatinSolution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4HMG1 protein stimulates DNA end joining by promoting association of DNA molecules via their endsA role of basic residues and the putative intercalating phenylalanine of the HMG-1 box B in DNA supercoiling and binding to four-way DNA junctionsHigh mobility group B1 protein interacts with its receptor RAGE in tumor cells but not in normal tissuesDNA binding by single HMG box model proteins.Replication protein A (RPA) binding to duplex cisplatin-damaged DNA is mediated through the generation of single-stranded DNA.Order of assembly of human DNA repair excision nuclease.Photoaffinity labeling reveals nuclear proteins that uniquely recognize cisplatin-DNA interstrand cross-linksThe effect of chromatin structure on cisplatin damage in intact human cells.The major chromatin protein histone H1 binds preferentially to cis-platinum-damaged DNAHMGB1: the jack-of-all-trades protein is a master DNA repair mechanic.High mobility group chromosomal protein 1 binds to the adeno-associated virus replication protein (Rep) and promotes Rep-mediated site-specific cleavage of DNA, ATPase activity and transcriptional repression.HMG proteins and DNA flexibility in transcription activationTranscription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitroTriplex technology in studies of DNA damage, DNA repair, and mutagenesis
P2860
Q21093380-72232C7D-23CF-44F8-95BD-0476CE8C71F4Q24292041-C456AE35-A162-4157-BCF4-11DFFDB28F40Q24294378-9CDF6E4F-A9BB-4503-9B38-259C6AE5C05EQ24311393-6B77F29E-2C1E-4EF9-BFBB-4BA97CBB787FQ24323101-22C1792A-4947-438D-8EEC-5AD2AE0F9B96Q24554431-AA74DFD3-D2D6-4A21-A981-CC31029FCB91Q24554531-849290FC-940C-49E0-B100-67C1BBBF5C59Q24562013-E19C03C3-5122-416B-B164-848E6833FB08Q24563372-D16C466C-8068-4A67-97BB-7D7E952F24D7Q24622867-84A8AF1E-1BF2-4E09-96C9-5F4137ED3FEBQ24792540-5A0183AF-F2A1-434A-92DA-7604D1E5F49EQ24795931-D6E4A155-672D-4049-929E-EA673A6CD5BDQ27618091-06017D00-F913-474F-B736-CC469E59BD08Q27630794-59E4F8A3-D76B-49E6-88AB-0ED87F4C67D8Q27631688-572C9C56-988E-4984-8C82-31B99BD67558Q27732133-0B135AC9-0C1B-48E0-83CA-4B57AEDFF9C6Q27931887-F397C28C-CE53-417E-B5B5-F8C50E9D960EQ27934776-AA4A777D-4C61-4C9E-81AA-DC5D773E6C98Q27936131-399B737B-CC3C-468F-B96C-8F2F8BD252A2Q27937303-C144876A-E6AD-4FC2-944B-AE679E6CC0E5Q27938684-6425F6E1-60A2-4F10-A35F-5B146C3A7C52Q28066801-2B0D9F3C-AA16-4FED-BCF9-34C9E2737915Q28082382-359197D7-2958-43C8-9A9B-AA30DA2263EDQ28139455-FCABEFED-7A6B-4D28-9394-02BB7A40E692Q28188163-31232A60-BCDB-4CC0-825D-D37B8F38D911Q28271290-E905F20E-797A-4D60-9A71-444526171DD4Q28568795-77D5F0E1-40F8-4CA8-8A18-8E07A2CC68F2Q28571423-F1137010-9282-43B6-83B6-3206FFF6B1BCQ28577024-D7CF2205-B9BE-48FF-9D2F-4B6C20B9C3CBQ28580134-543952F1-E07E-4F60-9F4F-ECF799DFA913Q30631650-15981B84-5FCC-4360-B1DD-CC81158253FFQ31326797-3EEBDE1B-4BAC-4459-A362-7F30CE62A089Q33429678-49219D9C-2879-4FAB-BB61-E7A671668234Q33617354-81896103-7106-41D2-B1AD-25815F027FFCQ33705040-9DC874CA-9DF1-4A91-BED2-A565C529E8B4Q33799406-C0A28C34-3BC0-4AF2-9DBE-4F2140A8E1ADQ33887580-E318EF63-EEAC-486B-BBD5-49355674D052Q34012305-CECACD9C-B3D7-4740-B41E-B1875E1AD0E6Q34047176-4E862EB7-1F5E-4E46-873D-BBC48693C3C3Q34179182-DBBE7D09-CB1E-48BB-BE10-376772990776
P2860
Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Specific binding of chromosoma ...... the anticancer drug cisplatin.
@en
type
label
Specific binding of chromosoma ...... the anticancer drug cisplatin.
@en
prefLabel
Specific binding of chromosoma ...... the anticancer drug cisplatin.
@en
P356
P1433
P1476
Specific binding of chromosoma ...... the anticancer drug cisplatin.
@en
P2093
P304
P356
10.1126/SCIENCE.1566071
P407
P577
1992-04-01T00:00:00Z